Rapid Micro Biosystems, Inc. (RPID)
USD 2.1
(-3.23%)
USD 2.1
(-3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -45.08 Million | -58.54 Million | -54.96 Million | -30.99 Million | -21.14 Million |
| Net Income | -52.46 Million | -60.8 Million | -73.52 Million | -37.07 Million | -21.17 Million |
| Depreciation & Amortization | 3.1 Million | 2.83 Million | 1.52 Million | 1.5 Million | 1.46 Million |
| Deferred income taxes | 2.42 Million | - | 22.78 Million | 3.13 Million | -249 Thousand |
| Stock-based compensation | 4.75 Million | 4.01 Million | 1.84 Million | 533 Thousand | 473 Thousand |
| Change in working capital | 555 Thousand | -5.32 Million | -7.99 Million | -1.09 Million | -2.1 Million |
| Other non-cash items | -3.44 Million | 728 Thousand | 404 Thousand | 2 Million | 449 Thousand |
| Investing Cash Flow | 42.15 Million | -93.46 Million | -13.28 Million | -15.67 Million | -1.69 Million |
| Investments in PPE | -1.84 Million | -6.74 Million | -3.21 Million | -690 Thousand | -1.69 Million |
| Acquisitions | -43.99 Million | 86.72 Million | 20 Thousand | 14.98 Million | - |
| Investment purchases | -62.49 Million | -179.22 Million | -25.09 Million | -24.98 Million | - |
| Sales/Maturities of investments | 106.49 Million | 92.5 Million | 15 Million | 10 Million | - |
| Other Investing Activities | 43.99 Million | -86.72 Million | -10.07 Million | -14.98 Million | - |
| Financing Cash Flow | 149 Thousand | 693 Thousand | 216.74 Million | 64.23 Million | 14.87 Million |
| Debt repayment | -37 Thousand | -33 Thousand | -26.17 Million | -18 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | 180 Thousand | 160 Thousand | - | - | - |
| Common Stock Issuance | 186 Thousand | 726 Thousand | 164.11 Million | 72 Thousand | 11 Thousand |
| Other Financing Activities | 186 Thousand | 726 Thousand | 78.8 Million | 82.16 Million | 14.85 Million |
| Accounts receivables | -163 Thousand | -364 Thousand | -17 Thousand | -1.36 Million | -511 Thousand |
| Accounts payables | -3.45 Million | 1.48 Million | -524 Thousand | 978 Thousand | 1.03 Million |
| Inventory | 1.19 Million | -5.84 Million | -6.76 Million | -3.36 Million | -3.92 Million |
| Other working capital | 2.98 Million | -602 Thousand | -691 Thousand | 2.65 Million | 1.29 Million |
| Cash at beginning of period | 27.06 Million | 178.67 Million | 30.17 Million | 12.61 Million | 20.58 Million |
| Cash at end of period | 24.28 Million | 27.34 Million | 178.67 Million | 30.17 Million | 12.61 Million |
| Capital Expenditure | -1.84 Million | -6.74 Million | -3.21 Million | -690 Thousand | -1.69 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -2.77 Million | -151.32 Million | 148.49 Million | 17.56 Million | -7.97 Million |
| Free Cash Flow | -46.92 Million | -65.28 Million | -58.18 Million | -31.68 Million | -22.84 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.57 Million | -13.32 Million | -52.46 Million | -11.17 Million | -13.39 Million | -14.01 Million |
| Depreciation & Amortization | 828 Thousand | 1.11 Million | 3.1 Million | 794 Thousand | 781 Thousand | 771 Thousand |
| Deferred income taxes | - | - | 2.42 Million | 1.18 Million | -560 Thousand | -620 Thousand |
| Stock-based compensation | 1.17 Million | 1.08 Million | 4.75 Million | 1.02 Million | 1.25 Million | 1.23 Million |
| Change in working capital | 526 Thousand | -3.99 Million | 555 Thousand | 76 Thousand | 1.89 Million | 3.13 Million |
| Other non-cash items | 2.85 Million | 3.64 Million | -3.44 Million | -1.39 Million | 314 Thousand | 305 Thousand |
| Investing Cash Flow | 24.81 Million | 13.51 Million | 42.15 Million | 10 Million | 4.76 Million | 13.46 Million |
| Investments in PPE | -459 Thousand | -585 Thousand | -1.84 Million | -418 Thousand | -453 Thousand | -215 Thousand |
| Acquisitions | - | - | -43.99 Million | 28.35 Million | -5.21 Million | -13.68 Million |
| Investment purchases | 12 Thousand | -4.38 Million | -62.49 Million | -11.56 Million | -24.28 Million | -8.81 Million |
| Sales/Maturities of investments | 25.26 Million | 18.48 Million | 106.49 Million | 21.99 Million | 29.5 Million | 22.5 Million |
| Other Investing Activities | - | 14.1 Million | 43.99 Million | -28.35 Million | 5.21 Million | 13.68 Million |
| Financing Cash Flow | -10 Thousand | 158 Thousand | 149 Thousand | -12 Thousand | 48 Thousand | -9000.00 |
| Debt repayment | -10 Thousand | -10 Thousand | -37 Thousand | -10 Thousand | -9000.00 | -9000.00 |
| Dividends payments | - | - | - | -7000.00 | - | - |
| Common Stock Repurchased | - | 168 Thousand | 180 Thousand | -2000.00 | - | - |
| Common Stock Issuance | - | 168 Thousand | 186 Thousand | -2000.00 | 57 Thousand | - |
| Other Financing Activities | - | 168 Thousand | 186 Thousand | 13 Thousand | 57 Thousand | - |
| Accounts receivables | -90 Thousand | 611 Thousand | -163 Thousand | -1.62 Million | -451 Thousand | 2.05 Million |
| Accounts payables | 1.01 Million | -809 Thousand | -3.45 Million | -1.29 Million | 1.9 Million | 77 Thousand |
| Inventory | -1.02 Million | -543 Thousand | 1.19 Million | 233 Thousand | 747 Thousand | 4000.00 |
| Other working capital | 621 Thousand | -3.25 Million | 2.98 Million | 2.76 Million | -305 Thousand | 1 Million |
| Cash at beginning of period | 22.43 Million | 24.28 Million | 27.06 Million | 23.78 Million | 28.96 Million | 24.69 Million |
| Cash at end of period | 37.12 Million | 22.43 Million | 24.28 Million | 24.28 Million | 24.07 Million | 28.96 Million |
| Capital Expenditure | -459 Thousand | -585 Thousand | -1.84 Million | -418 Thousand | -453 Thousand | -215 Thousand |
| Effect of forex changes on cash | - | - | - | 4.25 Million | - | -4.25 Million |
| Net cash flow / Change in cash | 14.68 Million | -1.85 Million | -2.77 Million | 499 Thousand | -4.89 Million | 4.27 Million |
| Free Cash Flow | -10.57 Million | -16.11 Million | -46.92 Million | -9.91 Million | -10.16 Million | -9.4 Million |
CWBHF
ASR
1303
APL
NUMIF
0003